Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2013 Mar 1.

Published in final edited form as: Dig Dis Sci. 2011 Sep 28;57(3):806–812. doi: 10.1007/s10620-011-1910-9

Table 2.

Explant and post-DDLT characteristics of patients with and without post-DDLT HCC recurrence

	HCC Recurrence		P-Value
	Yes (N=17)	No (N=77)	P-Value

Explant Characteristics
Within Milan	7(44%)	53 (75%)	0.033
T1 Stage	0	5(7%)	0.017
T2 Stage	7(44%)	48 (67%)
> T2 Stage (outside Milan)	9 (56%)	19 (26%)
No HCC	1 (6%)	5 (7%)	1.0
Lesions	2(0–7)	1 (0–7)	0.2
Largest Diameter	3.1 (1.5–7)	2.85 (1–6.5)	0.31
Total size	5.8 (0–10.9)	3.4 (0–11)	0.02
Micro invasion	3(18%)	15 (20%)	1.0

Tacrolimus	14(82%)	64 (83%)	1.0
Cyclosporine	3(18%)	13(17%)

Rejection	1(6%)	5(7%)	1.0

No. of deaths	10(59%)	11 (14%)	<0.0001

Follow up time (years)	2.0 (0.2–6.4)	2.3 (0.1–6.6)	0.39